GNFT Genfit

添加自选

3.670
+0.120+3.38%

收盘价 03/28 16:00 (美东)

1.83亿总市值9.18市盈率TTM

关于Genfit公司

Genfit SA 是一家专注于代谢和炎症疾病的生物技术公司，尤其专注于肝脏和胃肠病学。该公司的研发活动依赖于其通过核受体调节基因表达的专业知识。Genfit利用收购、战略联盟和许可协议为其产品的进一步发展提供资金。它有一个部门专注于创新药物和诊断解决方案的研究和开发，其营销取决于临床开发阶段的成功。

公司介绍

公司代码GNFT

公司名称Genfit

上市日期2019/03/27

发行价格20.32

成立日期1999

CEOMr. Pascal Prigent

所属市场纳斯达克

员工数量159

证券类型存托凭证

ADS转换比例1.0 : 1.0

年结日12-31

公司地址Parc Eurasante,885, Avenue Eugène Avinée,Lille Métropole

城市Loos

省份HF

国家法国

邮编59120

电话33-3-20-16-40-00

网址http://www.genfit.com

董事高管

姓名
职务
年薪

Pascal Prigent
Chief Executive Officer
--

Stefanie Magner
Chief Compliance Officer and Executive Vice President, International Legal Affairs
--

Carol Addy
Chief Medical Officer
--

Thomas Baetz
Chief Financial Officer
--

Pascal Caisey
Chief Operating Officer
--

Jean-Christophe Marcoux
Chief Corporate Affairs Officer, Head of Investor Relations and Head of ESG
--

Dean Hum, PhD
Chief Scientific Officer
--

Dr. Meriam Kabbaj, PhD
Chief Technology Officer
--

Sayah-Jeanne Sakina
Executive Vice President, Research and Translational Science
--

Emilie Desodt
Executive Vice President, Human Resources
--

Tom Huijbers
Executive Vice President, Regulatory
--

John Brozek
Executive Vice President, Data and Information Technology
--

Xavier Guille des Buttes
Vice Chairman of the Board
--

Jean-Francois Mouney
Chairman of the Board
--

Sandra Silvestri
Director
--

Florence Sejourne
Director
--

Laurent Lannoo
Corporate Secretary and Director of Legal Affairs
--

Katherine Bach Kalin, M.B.A.
Independent Director
--

Anne-Helene Monsellato
Independent Director
--

Jean-Francois Tine
Independent Director
--

Eric Baclet
Independent Director
--

Dr. Catherine Larue, PhD
Independent Director
--

GNFT Genfit

关于Genfit公司

公司介绍

董事高管

热门市场机会